Skip to main content
Equibles

Baird Financial Group, Inc.

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1648711 MILWAUKEE, WI
Back to KPTI Full portfolio

Position in KPTI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$291,058
+$125,123 QoQ
Shares Held
29,791
0.0% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 96 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Baird Financial Group, Inc. holds $226,318,173 across 30 Biotechnology names. KPTI ranks #23 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 368,978 $105,147,660
2 REGN
Regeneron Pharmaceuticals, Inc.
 52,845 $32,950,970
3 INCY
Incyte Corp
 224,855 $25,489,561
4 EXEL
Exelixis, Inc.
 437,138 $23,784,676
5 INVA
Innoviva, Inc.
 274,391 $6,231,419
6 TWST
Twist Bioscience Corp
 49,862 $5,129,802
7 BBIO
BridgeBio Pharma, Inc.
 38,672 $2,880,290
8 ASND
Ascendis Pharma A/S
 10,735 $2,863,239

All Filings in KPTI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $291,058 29,791
2026-03-31 $165,935 29,791
2025-12-31 $206,028 27,993
2025-09-30 $169,595 25,932
2025-06-30 $45,392 10,532
2024-12-31 $30,284 44,800
2024-09-30 $31,374 37,800
2024-06-30 $31,942 36,800
2024-03-31 $31,408 20,800
2023-12-31 $11,937 13,800
2023-09-30 $18,492 13,800
2023-06-30 $24,702 13,800
2023-03-31 $104,932 26,975
2022-12-31 $64,943 19,101
2022-09-30 $99,322 18,191
2022-06-30 $76,322 16,923
2022-03-31 $125,562 17,037
2021-12-31 $127,423 19,817
2021-09-30 $102,897 17,680
2021-06-30 $175,089 16,966
2021-03-31 $164,301 15,618
2020-12-31 $238,577 15,412
2020-09-30 $205,042 14,044
2020-06-30 $253,398 13,379
2020-03-31 $248,615 12,942